Recall Therapeutics is pioneering a breakthrough platform for memory restoration in Alzheimer’s disease, with expansion into high-value indications across, oncology-related cachexia, and aging-associated sarcopenia — addressing multi-billion-dollar markets with a unified, disease-modifying approach.